Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Treatment of Idiopathic Chronic Pancreatitis (ICP) with ivacaftor in a Cystic Fibrosis (CF) carrier who also had a second inherited risk factor for pancreatitis called Methylmalonic Acidemia

Treatment of Idiopathic Chronic Pancreatitis (ICP) with ivacaftor in a Cystic Fibrosis (CF) carrier who also had a second inherited risk factor for pancreatitis called Methylmalonic Acidemia

Resource Type

CF Research News

Authors

Tin-Yun Tang, Vincent B Cruz, Laura L Konczal

References

J Cyst Fibros. 2021 Dec 30;S1569-1993(21)02174-3. doi: 10.1016/j.jcf.2021.12.013.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Theme

Nutrition/Gastroenterology [3]

Date

Thursday, December 30, 2021

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [4]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/treatment-idiopathic-chronic-pancreatitis-icp-ivacaftor-cystic

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-21-00190R2_FINAL_Konczal_020622.pdf [2] https://pubmed.ncbi.nlm.nih.gov/34974990/ [3] https://www.ecfs.eu/research-article-themes/nutritiongatroenterology [4] https://www.ecfs.eu/resource-guideline-type/other-guidelines